Preparation of 13C-labeled ceramide by acetic acid bacteria and its incorporation in mice

Journal of Lipid Research

Volumn 51, Issue 11, 2010, Pages 3389-3395

  Fukami, Hiroyuki ^a   Tachimoto, Hideki ^a   Kishi, Mikiya ^a   Kaga, Takayuki ^a   Waki, Hatsue ^b   Iwamoto, Machiko ^b   Tanaka, Yasukazu ^b  

^a Mizkan Group Corporation   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Acetobacter; Brain; Dihydroceramide; Skin epidermis; Sphingolipid; Stable isotope

Indexed keywords

ACETIC ACID; CARBON 13; CERAMIDE; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE;

ACETOBACTER; ACETOBACTER MALORUM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE TECHNIQUE; EPIDERMIS; LIPID ANALYSIS; LIPID METABOLISM; LIVER; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SYNAPTIC MEMBRANE;

ACETIC ACID; ACETOBACTER; ADMINISTRATION, ORAL; ANIMALS; CARBON ISOTOPES; CERAMIDES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; ISOTOPE LABELING; MALE; MICE; MICE, INBRED C57BL;

EID: 78149348100     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D009191     Document Type: Article

References (33)

1. Merrill, A. H., Jr., E. M. Schmelz, D. L. Dillehay, S. Spiegel, J. A. Shayman, J. J. Schroeder, R. T. Riley, K. A. Voss, and E. Wang. 1997. Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142: 208-225.
2. Sawai, H., N. Domae, and T. Okazaki. 2005. Current status and perspectives in ceramide-targeting molecular medicine. Curr. Pharm. Des. 11: 2479-2487.
3. Rawlings, A. V. 2003. Trends in stratum corneum research and the management of dry skin conditions. Int. J. Cosmet. Sci. 25: 63-95.
4. Imokawa, G., A. Abe, K. Jin, Y. Higaki, M. Kawashima, and A. Hidano. 1991. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96: 523-526.
5. Kim, D. W., J. Y. Park, G. Y. Na, S. J. Lee, and W. J. Lee. 2006. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis. Int. J. Dermatol. 45: 698-701.
6. Van Echten-Deckert, G., and T. Herget. 2006. Sphingolipid metabolism in neural cells. Biochim. Biophys. Acta. 1758: 1978-1994.
7. Tanaka, Y. 1998. Aging and synapses (in Japanese with English abstract). Advances in Neurological Sciences. 42: 728-738.
8. Posse de Chaves, E. I. 2006. Sphingolipids in apoptosis, survival and regeneration in the nervous system. Biochim. Biophys. Acta. 1758: 1995-2015.
9. Helge, J. W., A. Dobrzyn, B. Saltin, and J. Gorski. 2004. Exercise and training effects on ceramide metabolism in human skeletal muscle. Exp. Physiol. 89: 119-127.
10. Drozdowski, L. A., M. Suh, E. Park, M. T. Clandinin, and A. B. Thomson. 2007. Dietary gangliosides enhance in vitro glucose uptake in weanling rats. JPEN J. Parenter. Enteral Nutr. 31: 423-429.
11. Vesper, H., E. M. Schmelz, M. N. Nikolova-Karakashian, D. L. Dillehay, D. V. Lynch, and A. H. Merrill, Jr. 1999. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr. 129: 1239-1250.
12. Jian, B., M. de la Llera-Moya, L. Royer, G. Rothblat, O. Francone, and J. B. Swaney. 1997. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J. Lipid Res. 38: 734-744.
13. Bolin, D. J., and A. Jonas. 1996. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J. Biol. Chem. 271: 19152-19158.
14. Okazaki, T. 2005. Molecular targeting therapy for leukemia by sphingolipid ceramide (in Japanese with English abstract). Rinsho Byori. 53: 413-421.
15. Nilsson, A. 1968. Metabolism of sphingomyelin in the intestinal tract of the rat. Biochim. Biophys. Acta. 164: 575-584.
16. Nilsson, A. 1969. The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim. Biophys. Acta. 176: 339-347.
17. Nilsson, A. 1969. Metabolism of cerebroside in the intestinal tract of the rat. Biochim. Biophys. Acta. 187: 113-121.
18. Fujino, Y., S. Ito, H. Masai, and M. Fujimori. 1978. Studies on lipid components in Acetobacter (in Japanese with English abstract). Res. Bull. Obihiro Univ. 10: 917-925.
19. Saeki, A., M. Taniguchi, K. Matsushita, H. Toyama, G. Theeragool, N. Lotong, and O. Adachi. 1997. Microbiological aspects of acetate oxidation by acetic acid bacteria, unfavorable phenomena in vinegar fermentation. Biosci. Biotechnol. Biochem. 61: 317-323.
20. Ogawa, S., H. Tachimoto, and T. Kaga. 2010. Elevation of ceramide in Acetobacter malorum S24 by low pH stress and high temperature stress. J. Biosci. Bioeng. 109: 32-36.
21. Folch, J., M. Lees, and S. G. H. Sloane. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
22. Tanaka, Y., A. Hasegawa, and S. Ando. 1996. Impaired synaptic functions with aging as characterized by decreased calcium influx and acetylcholine release. J. Neurosci. Res. 43: 63-70.
23. Deykin, D., and R. K. Desser. 1968. The incorporation of acetate and palmitate into lipids by human platelets. J. Clin. Invest. 47: 1590-1602.
24. Stoffel, W., and I. Melzner. 1980. Studies in vitro on the biosynthesis of ceramide and sphingomyelin. A reevaluation of proposed pathways. Hoppe Seylers Z. Physiol. Chem. 361: 755-771.
25. Wakita, H., Y. Tokura, H. Yagi, K. Nishimura, F. Furukawa, and M. Takigawa. 1994. Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine. Arch. Dermatol. Res. 286: 350-354.
26. Kim, S., I. Hong, J. S. Hwang, J. K. Choi, H. S. Rho, D. H. Kim, I. Chang, S. H. Lee, M. O. Lee, and J. S. Hwang. 2006. Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Mol. Med. 12: 17-24.
27. Ito, A., and K. Horigome. 1995. Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J. Neurochem. 65: 463-466.
28. Harel, R., and A. H. Futerman. 1993. Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J. Biol. Chem. 268: 14476-14481.
29. Furuya, S., K. Ono, and Y. Hirabayashi. 1995. Sphingolipid biosynthesis is necessary for dendrite growth and survival of cerebellar Purkinje cells in culture. J. Neurochem. 65: 1551-1561.
30. Goodman, Y., and M. P. Mattson. 1996. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J. Neurochem. 66: 869-872.
31. Tsuji, S., M. Arita, and Y. Nagai. 1983. GQ1b, a bioactive ganglioside that exhibits novel nerve growth factor (NGF)-like activities in the two neuroblastoma cell lines. J. Biochem. 94: 303-306.
32. Skaper, S. D., R. Katoh-Semba, and S. Varon. 1985. GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions. Brain Res. 355: 19-26.
33. Schmelz, E. M., K. J. Crall, R. Larocque, D. L. Dillehay, and A. H. Merrill. 1994. Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J. Nutr. 124: 702-712.